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Edited by Giulio Superti-FurgaAbstract The CSF-1 receptor is a protein-tyrosine kinase that
regulates the renewal, diﬀerentiation and activation of mono-
cytes and macrophages. We have recently shown that the
CSF-1 receptor undergoes regulated intramembrane proteolysis,
or RIPping. Here, we report that RIPping can be observed in
response to pathogen-associated molecules, which act through
Toll-like receptors (TLRs). TLR-induced CSF-1 receptor RIP-
ping is largely independent of protein kinase C, while maximal
RIPping depends on Erk activation. Our studies show that
CSF-1 receptor RIPping can be activated by various intracellu-
lar signal transduction pathways and that RIPping is likely to
play an important role during macrophage activation.
 2008 Federation of European Biochemical Societies.
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CSF-1 regulates the proliferation and survival of cells of the
monocyte/macrophage lineage, their diﬀerentiation into mac-
rophages, and macrophage activation [1,2]. The receptor for
CSF-1 is a ligand activated protein-tyrosine kinase that utilizes
autophosphorylation sites to regulate kinase activity and to
control interactions with signaling proteins [1,2]. We previ-
ously reported that the CSF-1 receptor also undergoes regu-
lated intramembrane proteolysis, releasing the intracellular
domain from the plasma membrane, enabling it to move to
other compartments within the cell to participate in signaling
[3].
Regulated intramembrane proteolysis, or RIPping, is a con-
served process that consists of two consecutive proteolytic
cleavage events [4]. Integral membrane proteins are cleaved
within the extracellular region close to the plasma membrane,
resulting in ectodomain shedding, followed by cleavage within
the transmembrane region, yielding a soluble intracellular do-
main (ICD). Several metalloproteases, including TACE, have
been implicated in the ﬁrst cleavage [5]. Intramembrane cleav-
age is often carried out by c-secretase [6]. In the case of Notch,
the ICD translocates to the nucleus where it alters gene expres-
sion [6,7]. Thus far, two protein-tyrosine kinases, ErbB4 and*Corresponding author. Fax: +1 619 594 4634.
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doi:10.1016/j.febslet.2008.02.029the CSF-1 receptor, have been shown to undergo RIPping
[3,8]. RIPping is essential for the biological activity of Notch
and it may provide an alternate and still largely unexplored
signaling mechanism for receptor protein-tyrosine kinases.
Toll-like receptors (TLR), which are expressed on macro-
phages, recognize various pathogen-associated molecules,
including lipopolysaccharide, bacterial lipoproteins, double
stranded RNA, and bacterial DNA [9–11]. Upon ligand bind-
ing, TLRs initiate signaling pathways leading to the phosphor-
ylation of a variety of proteins, including the transcription
factors NF-jB, IRF3, and IRF5, culminating in increased pro-
duction of inﬂammatory cytokines. Thus, TLRs recognize
molecular patterns that are associated with pathogenic intrud-
ers and that function as essential activators of the innate
immune response [12].
We previously found that the CSF-1 receptor undergoes
RIPping induced by CSF-1, TPA, and LPS [3,13]. Here we
report that ligands for other TLRs also induce CSF-1 receptor
RIPping. RIPping in response to TLR activation is largely
independent of protein kinase C (PKC) or oxygen radical pro-
duction. Inhibition of MEK1/2 reduces CSF-1 receptor RIP-
ping, suggesting that stimulation of CSF-1 receptor RIPping
by TLRs involves Erk activation.2. Materials and methods
2.1. Reagents
Recombinant human CSF-1 was obtained from R&D Systems.
A polyclonal antiserum was raised against the kinase insert domain
of the murine CSF-1 receptor [14]. Lipopolysaccharide (Escherichia
coli O111:B4), lipid A (Salmonella minnesota Re 595), and U0126 were
from EMD Biosciences (San Diego, CA). Lipoteichoic acid (Staphylo-
coccus aureus), and polyinosinic–polycytidylic acid (pI:pC) were
obtained from Sigma (St. Louis, MO). DNA was isolated from
E. coli DH5a using the Easy-DNA kit according to the manufacturers
directions (Invitrogen, Carlsbad, CA). Phospho-speciﬁc antibody
directed against Erk1/2 (Thr202/Tyr204) was obtained from Cell
Signaling (Danvers, MA). An antibody directed against Erk1/2 was
obtained from Promega (Madison, WI).2.2. Cell culture and treatments
P388D1 mouse macrophages were grown, stimulated, and lysed as
described before [3]. Cells were seeded at 2–3 · 106 cells per 10 cm dish
two days prior to stimulation.2.3. Immunoprecipitation and Western analysis
Cleared lysates were incubated with a polyclonal anti-CSF-1 recep-
tor serum and proteins were collected using Protein A-sepharose. Sam-
ples were fractionated by SDS–PAGE and analyzed by anti-CSF-1
receptor immunoblotting as described previously [3].blished by Elsevier B.V. All rights reserved.
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3.1. TLR agonists induce CSF-1 receptor RIPping
LPS is a potent and physiologically relevant activator of
macrophages. Our results conﬁrm previous observations and
show that LPS induces CSF-1 receptor RIPping in a concen-
tration and time dependent fashion (Fig. 1). Proteins of 150,
130, and 55 kDa are seen on these blots. The 150 kDa protein
represents the mature receptor, present on the cell surface; the
130 kDa protein corresponds to a precursor protein, present in
the endoplasmic reticulum or Golgi apparatus; the 55 kDa
protein is produced by RIPping and represents the CSF-1
receptor ICD. To test whether CSF-1 receptor RIPping is an
integral part of macrophage activation, P388D1 cells were acti-
vated with lipid A, lipoteichoic acid, polyI:polyC, or bacterial
DNA, agonists of TLR4, TLR2, TLR3, and TLR9, respec-
tively [11]. Mammalian DNA was included as a negative con-
trol. Our results show that all TLR agonists that were tested
strongly induce CSF-1 receptor RIPping (Fig. 2).Fig. 1. LPS induces CSF-1 receptor RIPping. P388D1 cells were stimulated
for varying lengths of time (B) and CSF-1 receptor RIPping was analyzed by
blotting.
Fig. 2. CSF-1 receptor RIPping in response to TLR activation. P388D1 cells
(A), 10 lg/ml lipoteichoic acid (B), 25 lg/ml polyI:polyC (C), or 10 lg/ml bact
were treated for 20 min with increasing amounts of bacterial DNA or 10 lg3.2. TACE inhibitors block TLR-induced CSF-1 receptor
RIPping
The metalloprotease, TACE, is important for TNFa release
in response to LPS [15,16]. Here we have shown that pretreat-
ment of P388D1 cells with the TACE inhibitor, TAPI-0, abro-
gated both receptor downregulation and the appearance of the
ICD in response to LPS or bacterial DNA (Fig. 3). Thus,
TACE, or a related protease, is essential for CSF-1 receptor
RIPping downstream of both TLR4 and TLR9.
3.3. LPS-induced CSF-1 receptor RIPping is independent of
PKC
Activation of PKC leads to increased TACE activity [17]. To
determine whether PKC plays a role in LPS-induced RIPping,
P388D1 cells were treated for 24 h with TPA to downregulate
PKC, and then stimulated with LPS. Both the disappearance
of mature receptors and the generation of the ICD were unaf-
fected by prolonged pretreatment with TPA (Fig. 4). As
expected, downregulation of PKC abrogated subsequentwith increasing amounts of LPS for 20 min (A) or with 100 ng/ml LPS
CSF-1 receptor immunoprecipitation followed by anti-CSF-1 receptor
were treated for the indicated amounts of time with 100 ng/ml lipid A
erial DNA (D) and analyzed for CSF-1 receptor RIPping. P388D1 cells
/ml human DNA and analyzed for CSF-1 receptor RIPping (E).
Fig. 3. TLR-dependent CSF-1 receptor RIPping is inhibited by the TACE inhibitor, TAPI-0. P388D1 cells were pretreated for 1 h with TAPI-0,
stimulated with LPS (A), or bacterial DNA (B), and analyzed for CSF-1 receptor RIPping.
G. Glenn, P. van der Geer / FEBS Letters 582 (2008) 911–915 913TPA-induced CSF-1 receptor RIPping. These observations
suggest that TLR-induced RIPping is independent of PKC.
3.4. MAP kinase dependent and independent pathways are
important for LPS-induced CSF-1 receptor RIPping
We have conﬁrmed that LPS activates several protein
kinases in P388D1 cells, including IKK, p38 MAPK, JNK,
and Erk1/2 (data not shown). Pharmacological inhibitors were
used to assess the role of these kinases in LPS-induced CSF-1
receptor RIPping by pretreating P388D1 cells for 1 hour prior
to stimulation. With the exception of the MEK1/2 inhibitor,
U0126, none of the compounds tested had a signiﬁcant eﬀect
on LPS-induced CSF-1 receptor RIPping (data not shown).
In U0126-treated P388D1 cells there was a dose-dependent
decrease in LPS-induced CSF-1 receptor RIPping which corre-
lated with a dose-dependent inhibition of Erk1/2 activation
(Fig. 5). Thus, Erk activation is one of several pathways that
connect TLRs to CSF-1 receptor RIPping.Fig. 5. Inhibition of the MAP kinase pathway reduces LPS-induced
CSF-1 receptor RIPping. P388D1 cells were pretreated for 1 hour with
increasing amounts of the MEK1/2 inhibitor, U0126, stimulated with
100 ng/ml LPS for 20 min, and analyzed for CSF-1 receptor RIPping
(A). Whole cell lysates were analyzed for Erk activation (B) and Erk
levels (C).4. Discussion
Macrophages are found in most tissues of the body. They
are indispensable for our defense against foreign intruders
and for tissue development. Macrophages engage in phagocy-
tosis, the production of cytokines, and communicate with the
adaptive immune system [18,19]. Macrophages have been
implicated in various maladies, including autoimmunity, can-
cer, atherosclerosis, and obesity [19–21]. CSF-1 regulates the
renewal and survival of macrophages, recruits macrophages
to speciﬁc sites within the body, and helps regulate macro-
phage activation [1,2].
CSF-1 binds to a receptor protein-tyrosine kinase and uti-
lizes autophosphorylation to initiate signal transduction [1,2].
In this classical paradigm, receptor autophosphorylation sites
function as docking sites for cellular signaling proteins that
are activated or inactivated as a consequence of their interac-Fig. 4. Downregulation of PKC by chronic TPA treatment has little eﬀect on
24 h with 100 nM TPA or DMSO as a control, stimulated with 100 ng/ml LPtion with the receptor. To terminate signaling, receptors are
internalized and degraded in the lysosomes [22]. Recently it
has become clear that the CSF-1 receptor is also subject to
RIPping, which results in ectodomain shedding and release
of the ICD into the interior of the cell [3]. In other systems
studied, the ICD moves to the nucleus where it interacts with
various transcription factors to alter gene transcription [4,6].
Thus, while RIPping contributes to the removal of CSF-1
receptors from the cell surface, it also generates a soluble
ICD capable of regulating gene expression (Fig. 6). The
removal of receptors from the cell surface is referred to as
downregulation. We now know that CSF-1 receptorLPS-induced CSF-1 receptor RIPping. P388D1 cells were treated for
S (A) or 100 nM TPA (B), and analyzed for CSF-1 receptor RIPping.
Fig. 6. Pathways leading to CSF-1 receptor RIPping. Activation of Toll-like receptors causes activation of Erk 1 and 2 and a second unidentiﬁed
pathway leading to TACE activation. TACE mediates ectodomain shedding followed by intramembrane proteolysis carried out by c-secretase.
Following release from the plasma membrane the CSF-1 receptor ICD can travel to the nucleus, is ubiquitinated, and degraded in the proteasome
[3,13]. LPS-induced CSF-1 receptor RIPping is independent of PKC. However, activation of protein kinase C also results in CSF-1 receptor RIPping
[3,13]. The TPA-induced CSF-1 receptor downregulation observed previously is a consequence of receptor RIPping.
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lowed by lysosomal degradation, or by RIPping. The ﬁrst pro-
cess acts exclusively to terminate signaling. In contrast,
RIPping results in the generation of a soluble ICD that is
likely to function as a signaling intermediate.
Macrophage activation by LPS is mediated by TLR4, one of
a family of cell surface receptors that recognize pathogen-asso-
ciated molecular patterns [9–11]. It has become clear that
TLRs are essential for activation of the immune response
against microbial pathogens [23]. Previous work has shown
that treatment of macrophages with LPS leads to the downreg-
ulation of the CSF-1 receptor from the cell surface [16,24]. Our
work conﬁrms and extends these observations, showing that
the LPS-induced disappearance of the mature CSF-1 receptors
is mediated by RIPping (Fig. 3). Moreover, we have shown
that stimulation of other TLRs, including TLR2, TLR3, and
TLR9, also induces CSF-1 receptor RIPping (Fig. 2). These
observations reveal that physiologically relevant activators of
macrophages stimulate CSF-1 receptor RIPping, resulting in
the production of a soluble ICD. This is consistent with a mod-
el in which the CSF-1 receptor ICD functions in the signaling
network that triggers the innate immune response upon detec-
tion of pathogenic microorganisms.
What pathways do macrophages use to turn on RIPping?
We have shown previously that PKC activation can induce
CSF-1 receptor RIPping (Fig. 6). However, our current study
shows that PKC downregulation does not aﬀect LPS-induced
RIPping. There is also evidence linking the production of oxy-
gen radicals during macrophage activation to TACE activa-
tion [25]. While we found that hydrogen peroxide can induce
RIPping, our experiments show no eﬀect of free radical scav-
engers on LPS-induced CSF-1 receptor RIPping (data not
shown). We have used pharmacological inhibitors to show thatactivation of Erk1 and Erk2 downstream of TLR4 plays a role
in the activation of RIPping (Fig. 5). This is consistent with the
observation that TACE can bind to and is a substrate for Erk1
and Erk2 [26]. Together these observations support the pre-
mise that Erk activation is one of several processes that act
in concert to stimulate maximal RIPping (Fig. 6). The other
players in this seemingly complex network remain to be iden-
tiﬁed.
Currently two receptor protein-tyrosine kinases have been
shown to undergo RIPping, ErbB4 and the CSF-1 receptor.
ErbB4 RIPping is induced by its natural ligand, neuregulin.
In contrast, CSF-1 appears to be a poor inducer of CSF-1
receptor RIPping [13]. Physiologically relevant inducers of
CSF-1 receptor RIPping include ligands for TLRs, which
are essential activators of the innate immune response. Preli-
minary results indicate that a stable version of the ICD local-
izes to the nucleus (unpublished results). Thus, our model
holds that the CSF-1 receptor ICD travels to the nucleus to
regulate gene transcription upon release from the plasma
membrane, thereby contributing to the rapid changes in gene
transcription that occur during the onset of the innate immune
response. Our research eﬀorts are currently aimed at further
understanding the function of the CSF-1 receptor ICD in
the nucleus.
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